David Rosen, a partner and public policy lawyer at Foley & Lardner, discusses the agency’s recently wrapped Software Precertification (Pre-Cert) Pilot Program and what it means for the future of digital health regulation.
Q&A: The FDA’s challenge in regulating evolving digital health tools
